The global orthopedic surgical planning software market size is expected to reach USD 68.94 million by 2030, expanding at a CAGR of 6.4% during the forecast period, based on a new report by Grand View Research, Inc. This is attributed to the rising technological advancements in the field of orthopedic surgeries coupled with the increasing prevalence of orthopedic conditions such as arthritis, joint pain, and fractures. According to CDC, around 78 million people aged 18 years and older are anticipated to have doctor-diagnosed arthritis by 2040. Moreover, the rising geriatric population is expected to drive the demand for efficient and cost-effective orthopedic surgical planning software from 2023 to 2030.
The COVID-19 pandemic had a mixed effect on the medical industry, with some areas witnessing negative growth while others experienced positive growth. Many governments took the necessary decision to delay all non-emergency surgical treatment. This resulted in fewer hospital visits and the cancellation of a large number of elective surgeries.
The presence of prominent players such as EOS Imaging; Formus Labs Ltd; Stryker; Brainlab AG; mediCAD; PEEK HEALTH S.A; Radlink Inc.; Zimmer Biomet; RSA Biomedical; Corin Group; and Enhatch Inc. are positively influencing the market growth. Market players are performing various strategic initiatives such as new product launches, partnerships, collaborations, and acquisitions to strengthen their market position and expand their customer base. For instance, in July 2021, DePuy Synthes launched VELYS, a robotic-assisted knee replacement solution for surgical treatment in Australia.
Request a free sample copy or view report summary: Orthopedic Surgical Planning Software Market Report
Based on type, the pre-operative segment accounted for the largest market share of 77% in 2022 and is anticipated to show the fastest CAGR of 6.9% over the forecast period, owing to the rising awareness regarding benefits associated with the use of pre-operative surgical planning software
Based on delivery, the cloud-based segment accounted for the largest market share of 64.6% in 2022 and is expected to show the fastest CAGR of 6.6%, owing to its wide capabilities in orthopedic surgical planning, such as on-demand computing cycles, and application storage
By end-use, the hospitals segment dominated with a market share of 54.1% in 2022 and is anticipated to show the fastest CAGR of 6.7% from 2023 to 2030. The rising adoption of orthopedic surgical planning software by healthcare professionals to enhance operational efficiency and deliver consistently is anticipated to drive the growth
North America dominated the global orthopedic surgical planning software industry with a revenue share of 42.3% in 2022. The regional growth is attributed to the increasing technological advancements and the presence of well-established healthcare infrastructure. The Asia Pacific region is anticipated to showcase the fastest CAGR of 6.7% over the forecast period
Some of the major industry players are EOS Imaging; Formus Labs Ltd; Stryker; Brainlab AG; mediCAD; PEEK HEALTH S.A
Grand View Research has segmented the global orthopedic surgical planning software market based ontype, delivery, end-use, and region:
Orthopedic Surgical Planning Software Type Outlook (Revenue, USD Million, 2017 - 2030)
Pre-Operative
Post-Operative
Orthopedic Surgical Planning Software Delivery Outlook (Revenue, USD Million, 2017 - 2030)
Cloud-based
On-premise
Orthopedic Surgical Planning Software End-use Outlook (Revenue, USD Million, 2017 - 2030)
Hospitals
Orthopedic Clinics
Orthopedic Surgical Planning Software Regional Outlook (Revenue, USD Million, 2017 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Orthopedic Surgical Planning Software Market
EOS Imaging
Formus Labs Ltd
Stryker
Brainlab AG
mediCAD
PEEK HEALTH S.A.
Radlink Inc.
Zimmer Biomet
RSA Biomedical
Corin Group
Enhatch Inc.
"The quality of research they have done for us has been excellent..."